Announcement: Testimony to the National Citizens Inquiry Scheduled for Saturday June 1, 2024 at 1:30 EDT

(Lethal) Shedding of Spike mRNA "Gene Therapy" Products

Image 1. The COVID-19 mRNA gene therapy products are dangerous when used as vaccines because the lipid nanoparticles (LNPs) used in the vaccination campaign worldwide, bore spike protein and upon the generation of spike IgG1/3 following the second dose, targeted the LNPs to the protector foamy macrophages (known as sebocytes in the upper respiratory tract (URT)) by antibody dependent enhancement (ADE) of infection into macrophages. It is hypothesized that this converted the protector HERV-K102 protector particles into bioweaponized exosomes with bound spike IgG1/3 that when shed to others could cause microclotting, inflammation, complement activation, and platelet aggregation with a much higher risk of death than the early microclotting/myocarditis that occurred within 21 days of administration of the gene therapy shots.

Image 2. Data from the UK Office for National Statistics for England reveals evidence consistent with the shedding of protector HERV-K102 particles (horizontal transmission) to the unvaccinated after the first dose (A: reduced C19 and non-C19 mortality rates in the unvaccinated). In contrast, after the second dose (B) when the IgG1/3 spike antibodies are produced, the protector particles exhibit a reduced capacity to diminish non-C19 mortality rates while at the same time exhibit greatly increased C19 mortality rates in the vaccinated and the unvaccinated. These data are consistent with the notion that COVID-19 mRNA/cDNA gene therapy products extinguish essential herd immunity needed for the survival of Homo sapiens in response to pandemics through contamination of the HERV-K102 particles that are shed from the URT. Moreover, the spike-laden exosomes covered in spike IgG1/3 (putatively carrying spike mRNA/cDNA) are themselves deadly bioweapons that may swiftly and covertly cause microclotting and myocarditis injuries leading to sudden death.

Dear Colleagues,

My testimony on (Lethal) "Shedding of Spike mRNA Gene Therapy Products" with the recommendation for the banning of all mRNA gene therapy products as vaccines for humans and animals is scheduled for presentation;

on Saturday June 1, 2024 at 1:30 EST with the National Citizens Inquiry and will be broadcast here:

https://nationalcitizensinquiry.ca/live/ .

Please alert and notify anyone who may have interest in the subjects of the questionable safety and effectiveness of mRNA vaccines, why adaptive immunity vaccines administered during pandemics may be dangerous, and/or how mRNA gene therapy vaccines might turn shed protector HERV-K102 particles (that establish innate herd immunity) into bioweaponized exosomes that can kill without warning.

Many of you would not know that I had been working on how to mitigate the risks of infectious diseases and pandemics since 1996 when I was hired into the Blood and Tissues Division of the Bureau of Biologics and Radiopharmaceuticals at Health Canada in response to the interim Krever Report on the Tainted Blood Scandal (HIV-1 and Hep C) of the 80's and early 90's.

At the LCDC which became the Public Health Agency of Canada in 2004, we discovered the novel HERV-K102 "virus anti-virus" innate immunity response of macrophages that putatively is needed for prevention and/or recovery from pandemic viruses. We also developed a blood screening tool to screen blood donors for the presence of toxins and/or unidentified viruses/pathogens. Patent applications were made, but since have been abandoned.

Even my subsequent work as Lab and Research Director at ISM involved clinical experience in how to rebalance the plasma amino acid profile to reverse and prevent immunosenescence using nutraceuticals to reduce the risks of infectious diseases, cardiovascular disease and cancers.

I hope to convey to the world that gene therapy products should never again be used as vaccines and should be banned.

Sincerely,

Marian P. Laderoute, Ph.D. Medical Sciences - Immunology

Advocate for Research on HERV-K102 as a Protector Foamy Virus of Humans Against Emerging/Pandemic Viruses and for Controlling Chronic Diseases

(cancer, cardiovascular, autoimmune, neurological, etc.)

Subscribe to my posts:

hervk102.substack.com

hervk102.twitter.com